Prospective Wsg Phase Iii Planb Trial: Final Analysis Of Adjuvant 4xec -> 4x Doc Vs. 6x Docetaxel/Cyclophospham Ide In Patients With High Clinical Risk And Intermediate-To-High Genomic Risk Her2-Negative, Early Breast Cancer

Nadia Harbeck,Oleg Gluz,Michael R. Clemens,Wolfram Malter,Toralf Reimer,Benno Nuding,Bahriye Aktas,Andrea Stefek,Anke Pollmanns,Fatemeh Lorenz-Salehi,Christoph Uleer,Petra Krabisch,Sherko Kummel,Cornelia Liedtke,Steven Shak,Rachel Wuerstlein,Matthias Christgen,Ronald Kates,Hans Heinrich Kreipe,Ulrike Nitz

JOURNAL OF CLINICAL ONCOLOGY（2017）

引用 11|浏览122
暂无评分
关键词
prospective wsg phase,docetaxel/cyclophosphamide,early breast cancer,breast cancer,intermediate-to-high
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要